Personalized Fluid Resuscitation in the Emergency Department: A Pilot Trial
FLUID-ED
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this pilot clinical trial is to learn if a fluid assessment using non-invasive cardiac output monitoring (NICOM) is helpful for patients with sepsis who have low blood pressure in the Emergency Department (ED). The study will measure whether the NICOM assessment changes fluid resuscitation practices and is feasible in the ED setting. All patients will receive standard medical care. Patients assigned to the NICOM group will receive a one-time, non-invasive bedside fluid assessment using NICOM, in addition to standard care, and the results of the fluid assessment will be provided to the treating physician.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable sepsis
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 19, 2026
CompletedFirst Posted
Study publicly available on registry
August 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2028
August 25, 2026
August 1, 2026
1.4 years
August 19, 2026
August 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IV fluid volume (3-hour)
Total volume of IV resuscitative fluids received within 3 hours of enrollment. This will be measured as total volume and as a weight-based measure in mL/kg (using actual weight up to BMI 30 and ideal body weight for patients with BMI \>=30).
3 hours
Secondary Outcomes (6)
Sepsis bundle compliance (3-hour)
3 hours
Feasibility
Day 1
Sepsis bundle compliance (6-hour)
6 hours
Acceptability
Day 1
IV Fluid Volume (6 hour)
6 hours
- +1 more secondary outcomes
Other Outcomes (3)
ICU admission (safety)
Study day 1
Oxygen requirement (safety)
Study Day 1, Study Day 2
Diuresis (safety)
through Study Day 2
Study Arms (2)
NICOM Fluid Assessment
ACTIVE COMPARATORNICOM fluid assessment
Usual Care
NO INTERVENTIONParticipants will not receive any research intervention
Interventions
Trained study team members will perform a NICOM fluid assessment. This assessment involves performing a passive leg raise while measuring change in stroke volume (SV) with the non-invasive cardiac output monitor (NICOM). A SV change \>=10% during the passive leg raise indicates a patient is fluid responsive. The results of the NICOM fluid assessment will be provided to the patient's treating physician
Eligibility Criteria
You may qualify if:
- Adult patient being treated in the Intermountain Medical Center ED
- Patient has suspected sepsis. Suspected sepsis can be identified by a positive sepsis screen (standard screen completed by ED triage nurse), an active sepsis alert (which is triggered based on qualifying information or active by an ED nurse), or clinician report that patient has possible sepsis
- Patient is hypotensive OR has an initial lactate ≥4 mmol/L at the time of enrollment. Hypotension is defined as mean arterial pressure (MAP) \<65 mmHg or systolic blood pressure (SBP) \<90mmHg or patient is on vasopressors at time of enrollment.
You may not qualify if:
- Age \< 18 years
- Known pregnant patients
- Patients who are known to be incarcerated
- A trained and delegated study team member is not available to perform the NICOM fluid assessment
- Patient has been in the ED for \>6 hours or was transferred from an outside ED
- Patient has already received 30 ml/kg IV fluid or has this fluid volume ordered. Weight-based fluid dosing is calculated based on actual body weight for BMI \<30kg/m2 and ideal body weight for BMI ≥30 kg/m2
- Known clinical diagnosis of a condition potentially altering risk/benefit profile of NICOM-based fluid assessment, which may include
- Hemorrhagic shock (i.e.., active hemorrhage)
- Cardiogenic shock (i.e., hypotension suspected to be due to left or right ventricular failure)
- Obstructive shock (i.e., shock in the setting of known acute central pulmonary embolism, pneumothorax, or pericardial effusion)
- Active volume loss that requires fluid replacement per the treating clinician (i.e., injury due to burn)
- Acute stroke
- Acute myocardial infarction
- Status asthmaticus
- Status epilepticus
- +13 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Intermountain Medical Center Emergency Department
Murray, Utah, 84107, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2026
First Posted
August 21, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
May 1, 2028
Last Updated
August 25, 2026
Record last verified: 2026-08